Sept.30,2025 MUHC MGR “The PCP platform: Everything but the j.” by Dr. Emily McDonald,Division of ID скачать в хорошем качестве

Sept.30,2025 MUHC MGR “The PCP platform: Everything but the j.” by Dr. Emily McDonald,Division of ID

Title: “The PCP platform: Everything but the j.” Speaker: Dr. Emily McDonald (Dr. Todd Campbell Lee unable to co-present due to unforseen circumstances) Educational objectives: 1. Understand the clinical equipoise for low dose versus high dose septra for the treatment of PCP 2. Learn about novel adjunctive treatments for PCP 3. When septra isn't an option, we'll determine the standard of care for "what's next" 4. From treatment to prophylaxis Biosketch of Dr. Emily McDonald, Associate Professor, Division of General Internal Medicine: Dr. Emily McDonald is a clinician-scientist, general internist and epidemiologist. Dr. McDonald is an Associate Professor of Medicine in General Internal Medicine and the associate chair of Quality and Safety for the Department of Medicine. Dr. McDonald is an attending physician at the McGill University Health Centre and a scientist at the Research Institute of the McGill University Health Centre (RI-MUHC). She has completed medical school, fellowship and a Masters in Epidemiology at McGill University and post-graduate training in patient safety and quality improvement at Sunnybrook Health Sciences Centre as well as the Harvard T. H. Chan School of Public program in clinical effectiveness. Dr. McDonald is now the Director of the Canadian Medication Appropriateness and Deprescribing Network. Dr. McDonald's research focuses on interventions related to polypharmacy, medication safety and dosing strategies. A number of her studies on the appropriate use of hospital resources, tests and treatments have been published in high-impact peer-reviewed journals and several relating to safer prescribing in older adults have been featured in the media. In 2020-2021 she participated in and led a number of high-profile COVID-19 studies. Dr. McDonald happily supervises graduate students in the field of medication safety/optimization and has received funding from the CIHR, the Centre for Ageing and Brain Health Innovation, the Canadian Frailty Network and from the McGill Interdisciplinary Initiative in Infection and Immunity (MI-4). Biosketch of Dr. Todd Campbell Lee, Associate Professor of Medicine ID and GIM McGill University: Dr. Dr. Lee completed medical and subspecialty training at the University of Toronto followed by his Master's of Public Health at Harvard. He was elected to fellowship of the Infectious Diseases Society of America in 2019. Dr. Lee has multiple trials currently ongoing and funded by the CIHR and is one of the leaders of the internation S. Aureus Network Adaptive Platform Trial.